BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21382458)

  • 1. Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis.
    Hofkens W; Storm G; van den Berg WB; van Lent PL
    Int J Pharm; 2011 Sep; 416(2):486-92. PubMed ID: 21382458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: comparison of prednisolone with budesonide.
    Hofkens W; van den Hoven JM; Pesman GJ; Nabbe KC; Sweep FC; Storm G; van den Berg WB; van Lent PL
    Int J Pharm; 2011 Sep; 416(2):493-8. PubMed ID: 21382459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
    van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
    Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation.
    Hofkens W; Schelbergen R; Storm G; van den Berg WB; van Lent PL
    PLoS One; 2013; 8(2):e54016. PubMed ID: 23468840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenously delivered glucocorticoid liposomes inhibit osteoclast activity and bone erosion in murine antigen-induced arthritis.
    Hofkens W; Grevers LC; Walgreen B; de Vries TJ; Leenen PJ; Everts V; Storm G; van den Berg WB; van Lent PL
    J Control Release; 2011 Jun; 152(3):363-9. PubMed ID: 21396411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis.
    Metselaar JM; van den Berg WB; Holthuysen AE; Wauben MH; Storm G; van Lent PL
    Ann Rheum Dis; 2004 Apr; 63(4):348-53. PubMed ID: 15020326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis.
    van Lent PL; Grevers L; Blom AB; Sloetjes A; Mort JS; Vogl T; Nacken W; van den Berg WB; Roth J
    Ann Rheum Dis; 2008 Dec; 67(12):1750-8. PubMed ID: 18055478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1β, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis.
    Koenders MI; Marijnissen RJ; Devesa I; Lubberts E; Joosten LA; Roth J; van Lent PL; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2011 Aug; 63(8):2329-39. PubMed ID: 21520013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis.
    van Lent PL; Grevers LC; Blom AB; Arntz OJ; van de Loo FA; van der Kraan P; Abdollahi-Roodsaz S; Srikrishna G; Freeze H; Sloetjes A; Nacken W; Vogl T; Roth J; van den Berg WB
    Arthritis Rheum; 2008 Dec; 58(12):3776-87. PubMed ID: 19035520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
    Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
    Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes.
    Metselaar JM; Wauben MH; Wagenaar-Hilbers JP; Boerman OC; Storm G
    Arthritis Rheum; 2003 Jul; 48(7):2059-66. PubMed ID: 12847701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3.
    Blom AB; van Lent PL; Libregts S; Holthuysen AE; van der Kraan PM; van Rooijen N; van den Berg WB
    Arthritis Rheum; 2007 Jan; 56(1):147-57. PubMed ID: 17195217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis.
    van Meurs JB; van Lent PL; Holthuysen AE; Singer II; Bayne EK; van den Berg WB
    Arthritis Rheum; 1999 Jun; 42(6):1128-39. PubMed ID: 10366105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.
    Grevers LC; van Lent PL; Koenders MI; Walgreen B; Sloetjes AW; Nimmerjahn F; Sjef Verbeek J; van den Berg WB
    Arthritis Rheum; 2009 Feb; 60(2):396-407. PubMed ID: 19180490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity.
    Kluza E; Yeo SY; Schmid S; van der Schaft DW; Boekhoven RW; Schiffelers RM; Storm G; Strijkers GJ; Nicolay K
    J Control Release; 2011 Apr; 151(1):10-7. PubMed ID: 21130819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
    Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
    J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [(18)]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis.
    van der Geest T; Metselaar JM; Gerrits D; van Lent PL; Storm G; Laverman P; Boerman OC
    J Control Release; 2015 Jul; 209():20-6. PubMed ID: 25902038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint.
    Lippross S; Moeller B; Haas H; Tohidnezhad M; Steubesand N; Wruck CJ; Kurz B; Seekamp A; Pufe T; Varoga D
    Arthritis Rheum; 2011 Nov; 63(11):3344-53. PubMed ID: 21769848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cartilage oligomeric matrix protein (COMP) is modified by intra-articular liposomal clodronate in an experimental model of arthritis.
    Gomez-Barrena E; Lindroos L; Ceponis A; López-Franco M; Sanchez-Pernaute O; Mönkkönen J; Salo J; Herrero-Beaumont G; Konttinen Y
    Clin Exp Rheumatol; 2006; 24(6):622-8. PubMed ID: 17207376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.